SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?


To: Cymeed who wrote (617)12/19/1997 10:48:00 PM
From: Dr. Voodoo  Respond to of 887
 
Kind of feel like I should bring this up.

From press release: "Among patients receiving DepoCyt, median survival was 168 days, compared to 87 days among patients
receiving MTX."

Any FDA expertise regarding why this is "statistically insignificant" would be appreciated.

FWIW I think what they have works, they just did an incomplete job of proving it. Time will tell.

I have no DepoTech stock,but I may get some soon!



To: Cymeed who wrote (617)12/20/1997 12:04:00 AM
From: John Metcalf  Respond to of 887
 
Cymeed, in a few days information about the ODAC meeting will be available on "Federal Filings". You can access it through Dow Jones News Retrieval. (proprietary, don't post it here)